Cholecystokinin antagonists - PubMed (original) (raw)

Review

Cholecystokinin antagonists

G N Woodruff et al. Annu Rev Pharmacol Toxicol. 1991.

No abstract available

PubMed Disclaimer

Similar articles

• Cholecystokinin receptor antagonists: a review.
  Silverman MA, Greenberg RE, Bank S. Silverman MA, et al. Am J Gastroenterol. 1987 Aug;82(8):703-8. Am J Gastroenterol. 1987. PMID: 3300275 Review. No abstract available.
• The effect of cholecystokinin-receptor antagonists on cholecystokinin-stimulated bile flow in dogs.
  Westfall S, Andrus C, Schlarman D, Kaminski DL. Westfall S, et al. Surgery. 1991 Mar;109(3 Pt 1):294-300. Surgery. 1991. PMID: 2000561
• [Cholecystokinin antagonists: anxiolytic drugs of the future].
  Bourin M, Bradwejn J. Bourin M, et al. Pathol Biol (Paris). 1992 Mar;40(3):215-7. Pathol Biol (Paris). 1992. PMID: 1608663 Review. French. No abstract available.
• Cholecystokinin antagonists--a toxicologic perspective.
  Dethloff LA, de la Iglesia FA. Dethloff LA, et al. Drug Metab Rev. 1992;24(2):267-93. doi: 10.3109/03602539208996295. Drug Metab Rev. 1992. PMID: 1576938 Review. No abstract available.
• [Gastrin-/CCK-B antagonists are neuropharmacological tools].
  Oreland L. Oreland L. Lakartidningen. 1995 Feb 8;92(6):531-2. Lakartidningen. 1995. PMID: 7853937 Swedish. No abstract available.

Cited by

• Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
  Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW. Bishop LA, et al. Br J Pharmacol. 1992 May;106(1):61-6. doi: 10.1111/j.1476-5381.1992.tb14293.x. Br J Pharmacol. 1992. PMID: 1504732 Free PMC article.
• Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
  Akiyama T, Tachibana I, Otsuki M. Akiyama T, et al. Int J Pancreatol. 1993 Oct;14(2):167-73. doi: 10.1007/BF02786123. Int J Pancreatol. 1993. PMID: 7506744
• Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line.
  Jamshidipour R, Pinho EB, Hom DK, Howell SB. Jamshidipour R, et al. Cancer Chemother Pharmacol. 1994;34(6):484-90. doi: 10.1007/BF00685659. Cancer Chemother Pharmacol. 1994. PMID: 7923559
• Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
  Roberts SP, Harper EA, Watt GF, Gerskowitch VP, Hull RA, Shankley NP, Black JW. Roberts SP, et al. Br J Pharmacol. 1996 Aug;118(7):1779-89. doi: 10.1111/j.1476-5381.1996.tb15604.x. Br J Pharmacol. 1996. PMID: 8842444 Free PMC article.
• On the role of cholecystokinin in pancreatic cancer.
  Herrington MK, Adrian TE. Herrington MK, et al. Int J Pancreatol. 1995 Apr;17(2):121-38. doi: 10.1007/BF02788530. Int J Pancreatol. 1995. PMID: 7622936 Review. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database